Heart failure is a global health burden, with an estimated prevalence of more than 56 million individuals worldwide.¹ Notably, heart failure is highly associated with poor quality of life, frequent admissions to hospital, rising health-care costs, and high mortality rates. This complex clinical syndrome poses challenges to therapeutic interventions of heart failure, especially since a higher comorbidity burden leads to greater heart failure hospitalisation and all-cause mortality.²

中文翻译：

---

当代心力衰竭和合并症风险管理


心力衰竭是一项全球健康负担，据估计，全球心力衰竭的患病率超过 5600 万人。¹ 值得注意的是，心力衰竭与生活质量差、频繁住院、医疗保健费用上升和高死亡率高度相关。这种复杂的临床综合征对心力衰竭的治疗干预构成了挑战，特别是因为较高的合并症负担会导致更多的心力衰竭住院和全因死亡率。^{阿拉伯数字}